New effective sources of the Staphylococcus simulans lysostaphin

Journal of Biotechnology

Volumn 117, Issue 2, 2005, Pages 203-213

  Szweda, Piotr ^a   Kotłowski, Roman ^a   Kur, Józef ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Expression; Peptidase; Peptidoglycan; Purification; Staphylococci

Indexed keywords

AMINO ACIDS; CHROMATOGRAPHY; ENZYMES; ESCHERICHIA COLI; GENES; PH EFFECTS; PROTEINS;

FUSION PROTEINS; GENE ENCODING; LYSOSTAPHIN; METAL-AFFINITY CHROMATOGRAPHY;

BIOTECHNOLOGY;

AMINO ACID; BLOOD CLOTTING FACTOR 10A; COBALT; COPPER ION; EDETIC ACID; HISTIDINE; HYBRID PROTEIN; LYSOSTAPHIN; NICKEL; RECOMBINANT ENZYME; SEPHAROSE; THIOREDOXIN; ZINC ION;

AFFINITY CHROMATOGRAPHY; ALKALINITY; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME PURIFICATION; ENZYME SYNTHESIS; ESCHERICHIA COLI; EXPRESSION VECTOR; HIGH TEMPERATURE PROCEDURES; MOLECULAR CLONING; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING; STAPHYLOCOCCUS SIMULANS;

ESCHERICHIA COLI; STAPHYLOCOCCI; STAPHYLOCOCCUS SIMULANS;

EID: 16844386400     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2005.01.012     Document Type: Article

References (40)

1. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein - dye binding Anal. Biochem. 72 1976 248 254
2. A.J. Bramley, and R. Foster Effects of lysostaphin on Staphylococcus aureus infections of the mouse mammary gland Res. Vet. Sci. 49 1990 120 121
3. C. Cavadini, C. Hertel, and W.P. Hammes Stable expression of the lysostaphin gene meat Lactobacilli by introducing deletions within the prosequence Syst. Appl. Microbiol. 19 1996 21 27
4. C. Cavadini, C. Hertel, and W.P. Hammes Application of lysostaphin-producing lactobacilli to control staphylococcal food poisoning in meat products J. Food Prot. 61 1998 419 424
5. E. Chan Expression and purification of recombinant lysostaphin in Escherichia coli Biotechnol. Lett. 18 1996 833 838
6. M.W. Climo, R.L. Patron, B.P. Goldstein, and G.L. Archer Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob. Agents Chemother. 42 1998 1355 1360
7. J.J. Dajcs, E.B.H. Hume, J.M. Moreau, A.R. Caballero, B.M. Cannon, and R.J. O'Callaghan Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit Invest. Ophthalmol. Vis. Sci. 41 2000 1432 1437
8. J.J. Dajcs, B.A. Thiobodeaux, E.B.H. Hume, X. Zheng, G.D. Sloop, and R.J. O'Callaghan Lysostaphin is effective in treating methicilin-resistant Staphylococcus aureus endphthalmitis in the rabbit. Curr. Eye Res. 22 2001 451 457
9. H.P. DeHart, H.E. Heath, L.S. Heath, P.A. LeBlanc, and G.L. Sloan The lysostaphin endopeptidase gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus Appl. Environ. Microbiol. 61 1995 1475 1479
10. B.L.M. de Jonge, T. Sidow, Y.S. Chang, H. Labischinski, B. Berger-Bachi, D.A. Gage, and A. Tomasz Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus J. Bacteriol. 175 1993 2779 2782
11. K. Ehlert, M. Tschierske, C. Mori, W. Schröder, and B. Berger-Bächi Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the staphylococcal peptidoglycan interpeptide bridge J. Bacteriol. 182 2000 2635 2638
12. R.I. Harris, A.W. Nunnery, and H.D. Riley Effects of lysostaphin on staphylococcal carriage in infants and children. Antimicrob. Agents Chemother. 7 1967 110 112
13. H.E. Heath, L.S. Heath, J.D. Nitterauer, K.E. Rose, and G.L. Sloan Plasmid encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphyloticus Biochem. Biophys. Res. Commun. 160 1989 1106 1109
14. L.S. Heath, H.E. Heath, and G.L. Sloan Plasmid-encoded lysostaphin endopeptidase of Staphylococcus simulans biovar staphyloticus FEMS Microbiol. Lett. 44 1987 129 133
15. P. Heinrich, R. Rosenstein, M. Bohmer, P. Sonner, and F. Gotz The molecular organization of the lysostaphin gene and its sequences repeated in tandem Mol. Gen. Genet. 209 1987 563 569
16. C. Hertel, A.J. Probst, C. Cavadini, E. Meding, and W.P. Hammes Safety assessment of genetically modified microorganisms applied in meat fermentations Syst. Appl. Microbiol. 18 1995 469 476
17. O. Iversen, and A. Grov Studies on lysostaphin. Separation and characterization of three enzymes Eur. J. Biochem. 38 1973 293 300
18. D.E. Kerr, K. Plaut, A.J. Bramley, C.M. Williamson, A.J. Lax, K. Moore, K.D. Wells, and R.J. Wall Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice Nat. Biotech. 19 2001 66 70
19. J.F. Kokai-Kun, S.M. Walsh, T. Canturiya, and J.J. Mond Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model Antimicrob. Agents Chemother. 47 2003 1589 1597
20. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
21. H. Maidhof, B. Reinicke, P. Blumel, B. Berger-Bachi, and H. Labischinski femA, which encodes a factor essential for expression of methicilin resistance, affects glycine content of peptidoglycan in methicilin-resistant and methicilin-susceptible Staphylococcus aureus strains J. Bacteriol. 173 1991 3507 3513
22. I. Marova, and J. Kovar Spectrophotometric detection of bacteriolytic activity of diluted lysostaphin solutions. Folia Microbiol. 38 1993 153 158
23. E.R. Oldham, and M.J. Daley Lysostaphin: use of recombinant bactericidal enzyme as a mastitis therapeutic J. Dairy Sci. 74 1991 4175 4182
24. P.W. Park, R.M. Senior, G.L. Griffin, T.J. Broekelmann, M.S. Mudd, and R.P. Mecham Binding and degradation of elastin by the staphylolytic enzyme lysostaphin Int. J. Biochem. Cell Biol. 27 1995 139 146
25. R.L. Patron, M.W. Climo, B.P. Goldstein, and G.L. Archer Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin Antimicrob. Agents Chemother. 43 1999 1754 1755
26. K.E. Quickel, R. Selden, J.R. Caldwell, N.F. Nora, and W. Scheffner Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus Appl. Microbiol. 22 1971 446 450
27. P.A. Recsei, A.D. Gruss, and R.P. Novick Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans Proc. Natl. Acad. Sci. U.S.A. 84 1987 1127 1131
28. J.M. Robinson, J.K. Hardman, and G.L. Sloan Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus J. Bacteriol. 137 1979 1158 1164
29. C.A. Schindler, and V.T. Schuhardt Lysostaphin: a new bacteriolytic agent for the Staphylococcus Proc. Natl. Acad. Sci. U.S.A. 51 1964 414 421
30. C.A. Schindler, and V.T. Schuhardt Purification and properties of lysostaphin - a lytic agent for Staphylococcus aureus. Biochim. Biophys. Acta 97 1965 242 250
31. K.H. Schleifer, and O. Kandler Peptidoglycan types of bacterial cell walls and their taxonomic implications Bacteriol. Rev. 36 1972 407 477
32. G.L. Sloan, J.M. Robinson, and W.E. Kloos Identification of 'Staphylococcus staphylolyticus' as a biovar of Staphylococcus simulans Int. J. Syst. Bacteriol. 32 1982 170 174
33. F.R. Stark, C. Thornsvard, E.P. Flannery, and M.S. Artestein Systematis lysostaphin in man: apparent antimicrobial activity in a neutropenic patient N. Engl. J. Med. 291 1974 1355 1360
34. P. Szweda, R. Pladzyk, R. Kotłowski, and J. Kur Cloning, expression, and purification of the Staphylococcus simulans lysostaphin using the Intein-Chitin-Binding Domain (CBD) system. Protein Expr. Purif. 22 2001 467 471
35. G. Thumm, and F. Gotz Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphyloticus Mol. Microbiol. 23 1997 1251 1265
36. C.M. Williamson, A.J. Bramley, and A.J. Lax Expression of the lysostaphin gene of Staphylococcus simulans in a eukaryotic system Appl. Environ. Microbiol. 60 1994 771 776
37. J.A. Wu, C. Kusuma, J.J. Mond, and J.F. Kokai-Kun Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces Antimicrob. Agents Chemother. 47 2003 3407 3414
38. C. von Eiff, J.F. Kokai-Kun, K. Becker, and G. Peters In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood Antimicrob. Agents Chemother. 47 2003 3613 3615
39. R.-Q. Zhou, S.-G. Chen, and A.P. Recsei Prolysostaphin-processing protease from Staphylococcus simulans - purification and some properties Acta Biochim. Biophys. Sin. 21 1989 65 71
40. W.A. Zygmunt, and P.A. Tawormina Model for a specific enzymatic approach to infectious disease Prog. Drug Res. 16 1972 309 333